| Literature DB >> 33306983 |
Pranvera Sadiku1, Joseph A Willson2, Eilise M Ryan2, David Sammut3, Patricia Coelho2, Emily R Watts2, Robert Grecian2, Jason M Young2, Martin Bewley3, Simone Arienti2, Ananda S Mirchandani2, Manuel A Sanchez Garcia2, Tyler Morrison2, Ailing Zhang2, Leila Reyes2, Tobias Griessler2, Privjyot Jheeta2, Gordon G Paterson2, Christopher J Graham2, John P Thomson4, Kenneth Baillie5, A A Roger Thompson3, Jessie-May Morgan2, Abel Acosta-Sanchez6, Veronica M Dardé6, Jordi Duran7, Joan J Guinovart8, Gio Rodriguez-Blanco9, Alex Von Kriegsheim9, Richard R Meehan4, Massimiliano Mazzone10, David H Dockrell2, Bart Ghesquiere6, Peter Carmeliet11, Moira K B Whyte2, Sarah R Walmsley12.
Abstract
Neutrophils can function and survive in injured and infected tissues, where oxygen and metabolic substrates are limited. Using radioactive flux assays and LC-MS tracing with U-13C glucose, glutamine, and pyruvate, we observe that neutrophils require the generation of intracellular glycogen stores by gluconeogenesis and glycogenesis for effective survival and bacterial killing. These metabolic adaptations are dynamic, with net increases in glycogen stores observed following LPS challenge or altitude-induced hypoxia. Neutrophils from patients with chronic obstructive pulmonary disease have reduced glycogen cycling, resulting in impaired function. Metabolic specialization of neutrophils may therefore underpin disease pathology and allow selective therapeutic targeting.Entities:
Keywords: COPD; GYS1; gluconeogenesis; glycogen; glycogenesis; glycogenolysis; glycolysis; inflammation; neutrophil
Mesh:
Substances:
Year: 2020 PMID: 33306983 PMCID: PMC7863914 DOI: 10.1016/j.cmet.2020.11.016
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287